Glaukos
Brian Collins is currently the Vice President of Market Development at Glaukos Corporation, a successful start-up with innovative technology in the glaucoma stent field. With a background in global marketing and extensive experience in the healthcare industry, Brian has held leadership positions at companies such as Abbott Laboratories, Covidien, Boston Scientific, and Baxter Healthcare. Brian obtained their MBA in Marketing & International Business from the Wisconsin School of Business.
Glaukos
3 followers
At Glaukos, their focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases—therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.